X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4796) 4796
Book Review (523) 523
Publication (203) 203
Book Chapter (12) 12
Newsletter (6) 6
Book / eBook (5) 5
Conference Proceeding (5) 5
Magazine Article (5) 5
Dissertation (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4337) 4337
humans (3503) 3503
male (2200) 2200
female (2003) 2003
gentamicin (1718) 1718
gentamicins - adverse effects (1692) 1692
middle aged (1288) 1288
gentamicins - therapeutic use (1281) 1281
adult (1218) 1218
gentamicins - administration & dosage (1206) 1206
animals (1169) 1169
aged (1102) 1102
anti-bacterial agents - adverse effects (927) 927
anti-bacterial agents - administration & dosage (870) 870
anti-bacterial agents - therapeutic use (762) 762
aminoglycosides (706) 706
abridged index medicus (671) 671
antibiotics (661) 661
pharmacology & pharmacy (602) 602
adolescent (494) 494
rats (453) 453
treatment outcome (440) 440
prospective studies (383) 383
kidney - drug effects (378) 378
surgery (370) 370
bacterial infections - drug therapy (368) 368
drug therapy, combination (365) 365
gentamicins - pharmacology (357) 357
nephrotoxicity (350) 350
aged, 80 and over (346) 346
child (330) 330
kidney diseases - chemically induced (328) 328
retrospective studies (325) 325
infectious diseases (324) 324
time factors (315) 315
infections (306) 306
infant, newborn (303) 303
health aspects (301) 301
otorhinolaryngology (295) 295
microbiology (294) 294
anti-bacterial agents - pharmacology (285) 285
risk factors (274) 274
vancomycin (269) 269
drug administration schedule (264) 264
infection (260) 260
urology & nephrology (256) 256
therapy (249) 249
microbial sensitivity tests (238) 238
ototoxicity (236) 236
toxicity (234) 234
dose-response relationship, drug (233) 233
pharmacokinetics (231) 231
acute kidney injury - chemically induced (230) 230
anti-bacterial agents - pharmacokinetics (222) 222
pediatrics (222) 222
analysis (214) 214
child, preschool (213) 213
creatinine - blood (211) 211
gentamicins - blood (208) 208
medicine, general & internal (207) 207
infant (205) 205
gentamicins - pharmacokinetics (199) 199
aminoglycosides - adverse effects (195) 195
orthopedics (194) 194
staphylococcal infections - drug therapy (181) 181
tobramycin (175) 175
drug therapy (169) 169
mice (167) 167
administration, topical (164) 164
bacteria (164) 164
follow-up studies (164) 164
gentamicins - toxicity (163) 163
medicine & public health (163) 163
prevention (161) 161
tobramycin - adverse effects (158) 158
sepsis - drug therapy (157) 157
surgical wound infection - prevention & control (155) 155
pseudomonas infections - drug therapy (148) 148
clinical trials as topic (147) 147
guinea pigs (147) 147
urinary tract infections - drug therapy (145) 145
toxicology (142) 142
efficacy (139) 139
care and treatment (138) 138
amikacin (137) 137
research (137) 137
amikacin - adverse effects (136) 136
pregnancy (135) 135
in-vitro (134) 134
drug resistance, microbial (133) 133
kidney - metabolism (133) 133
rabbits (131) 131
vancomycin - therapeutic use (130) 130
oxidative stress (128) 128
ophthalmology (127) 127
random allocation (127) 127
drugs (126) 126
drug therapy, combination - therapeutic use (125) 125
cochlea - drug effects (123) 123
peritonitis - drug therapy (121) 121
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4234) 4234
German (172) 172
French (118) 118
Japanese (59) 59
Spanish (49) 49
Chinese (37) 37
Russian (32) 32
Italian (30) 30
Polish (20) 20
Danish (19) 19
Czech (8) 8
Portuguese (6) 6
Hungarian (5) 5
Norwegian (5) 5
Slovak (5) 5
Bulgarian (4) 4
Hebrew (4) 4
Swedish (4) 4
Dutch (3) 3
Turkish (3) 3
Croatian (2) 2
Serbian (2) 2
Finnish (1) 1
Lithuanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 04/2019, Volume 14, Issue 4, p. e0214586
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2014, Volume 59, Issue 8, pp. 1083 - 1091
Background. Ceftriaxone is the foundation of currently recommended gonorrhea treatment. There is an urgent need for backup treatment options for patients with... 
Gemifloxacin | Neisseria gonorrhoeae | Gonorrhea treatment | Gentamicin | Azithromycin | INFECTIOUS DISEASES | CEFTRIAXONE | gemifloxacin | SUSCEPTIBILITY | RESISTANT NEISSERIA-GONORRHOEAE | GONOCOCCAL URETHRITIS | MICROBIOLOGY | azithromycin | IMMUNOLOGY | SEXUALLY-TRANSMITTED INFECTIONS | CEFIXIME | gonorrhea treatment | gentamicin | FLUOROQUINOLONE | IN-VITRO ACTIVITY | TREATMENT FAILURE | Gastrointestinal Diseases - epidemiology | Naphthyridines - adverse effects | United States | Humans | Middle Aged | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - adverse effects | Gastrointestinal Diseases - pathology | Adult | Female | Anti-Bacterial Agents - adverse effects | Gentamicins - adverse effects | Gentamicins - therapeutic use | Administration, Oral | Fluoroquinolones - therapeutic use | Treatment Outcome | Injections, Intramuscular | Gonorrhea - drug therapy | Fluoroquinolones - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Azithromycin - adverse effects | Neisseria gonorrhoeae - isolation & purification | Drug Therapy, Combination - methods | Azithromycin - therapeutic use | Naphthyridines - therapeutic use | Adolescent | Gastrointestinal Diseases - chemically induced | Care and treatment | Dosage and administration | Gonorrhea | Risk factors | Antimicrobial agents | Effectiveness | Drug therapy | Drug resistance | Product safety | Index Medicus | and Commentaries
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 07/2014, Volume 132, Issue 7, pp. 832 - 837
IMPORTANCE: Optisol-GS, the most common corneal storage medium in the United States, contains antibacterial but no antifungal supplementation. Most... 
VORICONAZOLE | PRESERVATION MEDIUM | DONOR CORNEAS | RIM CULTURES | PENETRATING KERATOPLASTY | ENDOTHELIAL-CELLS | SUSCEPTIBILITY | OPHTHALMOLOGY | FUNGAL ENDOPHTHALMITIS | EYE-BANKING | TRANSPLANTATION | Dextrans - adverse effects | Triazoles - adverse effects | Antifungal Agents - adverse effects | Cornea | Cell Count | Humans | Organ Preservation | Culture Media, Serum-Free - adverse effects | Drug Contamination - prevention & control | Colony Count, Microbial | Endothelium, Corneal - pathology | Candidiasis - microbiology | Microbial Sensitivity Tests | Candidiasis - prevention & control | Candida albicans - drug effects | Chondroitin Sulfates - adverse effects | Complex Mixtures - pharmacology | Endothelium, Corneal - microbiology | Dextrans - pharmacology | Gentamicins - pharmacology | Voriconazole | Culture Media, Serum-Free - pharmacology | Antifungal Agents - pharmacology | Organ Preservation Solutions - adverse effects | Gentamicins - adverse effects | Amphotericin B - pharmacology | Treatment Outcome | Chondroitin Sulfates - pharmacology | Organ Preservation Solutions - pharmacology | Endothelium, Corneal - drug effects | Pyrimidines - pharmacology | Complex Mixtures - adverse effects | Amphotericin B - adverse effects | Triazoles - pharmacology | Pyrimidines - adverse effects | Tissue Donors | Drug Combinations | Candida glabrata - drug effects | Care and treatment | Keratitis | Amphotericin B | Endophthalmitis | Dosage and administration | Diagnosis | Research | Risk factors | Fungal antigens | Index Medicus | Abridged Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2012, Volume 56, Issue 11, pp. 5811 - 5820
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, pp. e37281 - e37281
Formation of resilient biofilms on medical devices colonized by pathogenic microorganisms is a major cause of health-care associated infection. While in vitro... 
ANTIBIOTIC-LOCK TECHNIQUE | CONTROLLED-TRIAL | DIAGNOSIS | THERAPY | BACTEREMIA | IN-VIVO | BIOLOGY | ACCESS SYSTEM | MICE | CANCER | BLOOD-STREAM INFECTIONS | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Gentamicins - therapeutic use | Biofilms - growth & development | Pseudomonas Infections - complications | Rats | Male | Equipment Contamination | Staphylococcal Infections - complications | Anti-Bacterial Agents - therapeutic use | Animals | Staphylococcus epidermidis | Immunosuppression - adverse effects | Catheters, Indwelling - adverse effects | Models, Animal | Pseudomonas aeruginosa | Catheterization, Central Venous - adverse effects | Escherichia coli Infections - complications | Medical research | Medical equipment | Bacterial infections | Escherichia coli | Staphylococcus aureus infections | Medicine, Experimental | Cross infection | Nosocomial infections | Health aspects | Physiological apparatus | Staphylococcus aureus | Pediatrics | Surgical implants | Bioluminescence | Disseminated infection | Clinical trials | Infections | Microorganisms | E coli | Bacteria | Pathogens | Medical devices | Stability | Complications | Medical instruments | Staphylococcus infections | Disease control | Contamination | Catheters | Biofilms | Antibiotics | Colonization | Index Medicus | Cefazolin/therapeutic use | Escherichia coli infections | Biofilms/growth & development | Central Venous/adverse effects | Life Sciences | Staphylococcal Infections/complications/drug therapy | Pseudomonas Infections/complications | Bloodstream infections | Immunosuppression/adverse effects | Bacterial biofilms | Gentamicins/therapeutic use | Catheterization | Indwelling/adverse effects | Escherichia coli Infections/complications | bacterial pathogens | Bacteriology | Microbiology and Parasitology | Animal | Models | Anti-Bacterial Agents/therapeutic use
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2015, Volume 10, Issue 11, pp. e0142352 - e0142352
Objective The gut microbiota has been designated as an active regulator of glucose metabolism and metabolic phenotype in a number of animal and human... 
BILE-ACID METABOLISM | VANCOMYCIN | METAGENOME | TOLERANCE | MULTIDISCIPLINARY SCIENCES | SENSATIONS | APPETITE | IMPACTS | INSULIN SENSITIVITY | MODULATION | REPRODUCIBILITY | Humans | Male | Vancomycin - metabolism | Diarrhea - chemically induced | Insulin - blood | Young Adult | Feces - microbiology | Gentamicins - metabolism | Time Factors | Fasting - blood | Gentamicins - pharmacology | Vancomycin - pharmacology | Gastrointestinal Hormones - metabolism | Postprandial Period | Adult | Anti-Bacterial Agents - adverse effects | Thienamycins - adverse effects | Gentamicins - adverse effects | Anti-Bacterial Agents - metabolism | Treatment Outcome | Bacterial Load | Thienamycins - pharmacology | Vancomycin - adverse effects | Thienamycins - metabolism | Feces - chemistry | Gastrointestinal Microbiome - drug effects | Adolescent | Glucose - metabolism | Anti-Bacterial Agents - pharmacology | Gastrointestinal Hormones - blood | Blood Glucose - metabolism | Hormones | Vancomycin | Glucose | Males | Hormone release | Glucose metabolism | Body mass index | Microbiota | Rodents | Measurement methods | Bacteria | Blood pressure | Meropenem | Obesity | Cultivation | Secretion | Test procedures | Metabolism | Insulin | Fatty acids | Gentamycin | Glucose tolerance | Hospitals | Antibiotics | Insulin resistance | Diabetes | Long-term effects | Index Medicus
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 2014, Volume 210, Issue 9, pp. 1357 - 1366
Background. Limitations in treatment of biofilm-associated bacterial infections are often due to subpopulation of persistent bacteria (persisters) tolerant to... 
aminoglycoside | persister | catheter-related infections | biofilm | proton motive force | DIAGNOSIS | INFECTIOUS DISEASES | INFECTIONS | MANAGEMENT | TOLERANCE | SUSCEPTIBILITY | MICROBIOLOGY | IMMUNOLOGY | ANTIBIOTIC-LOCK THERAPY | GENTAMICIN | PSEUDOMONAS-AERUGINOSA | L-ARGININE | GROWTH | Escherichia coli Infections - prevention & control | Central Venous Catheters - microbiology | Escherichia coli - drug effects | Gentamicins - administration & dosage | Catheter-Related Infections - prevention & control | Pseudomonas Infections - prevention & control | Arginine - administration & dosage | Gentamicins - pharmacology | Drug Therapy, Combination | Biofilms - drug effects | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Pseudomonas Infections - drug therapy | Rats | Central Venous Catheters - adverse effects | Pseudomonas aeruginosa - drug effects | Catheter-Related Infections - drug therapy | Drug Synergism | Animals | Arginine - pharmacology | Staphylococcal Infections - prevention & control | Anti-Bacterial Agents - pharmacology | In Vitro Techniques | Staphylococcus aureus - drug effects | Hydrogen-Ion Concentration | Aminoglycosides | Health aspects | Research | Index Medicus | Abridged Index Medicus | Biofilms/drug effects | Gentamicins/administration & dosage | Anti-Bacterial Agents/pharmacology | Staphylococcal Infections/drug therapy | Arginine/administration & dosage | Life Sciences | Escherichia coli Infections/drug therapy | Staphylococcus aureus/drug effects | Gentamicins/pharmacology | Catheter-Related Infections/prevention & control | Pseudomonas aeruginosa/drug effects | Staphylococcal Infections/prevention & control | Catheter-Related Infections/drug therapy | Central Venous Catheters/microbiology | Escherichia coli/drug effects | Bacteriology | Microbiology and Parasitology | Central Venous Catheters/adverse effects | Arginine/pharmacology | Pseudomonas Infections/prevention & control | Escherichia coli Infections/prevention & control | Pseudomonas Infections/drug therapy
Journal Article
The Journal of Arthroplasty, ISSN 0883-5403, 07/2018, Volume 33, Issue 7, pp. 2225 - 2229
Journal Article